The institutional cluster is too small in dollar terms to signal a shared thesis. Monitor upcoming 13F filings for larger position changes or new activist/hedge fund entries that would indicate a catalyst.
ORKA drugs
ORKA drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $99.55entry
- T+1 · 13d ago +1.87%α +0.22% · $101.41
- T+5 · 7d ago +9.99%α +10.58% · $109.50
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Three asset managers added small positions in Oruka Therapeutics during Q3 2026, with total buying of $1.1M and no selling. The cluster is very small in dollar terms relative to the $6.4B market cap and lacks insider corroboration, indicating limited conviction.
Key Financial Metrics
Institutional Positions
Net institutional flow: $1.1M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Principal Financial Group | ADD | +47.9% | $4.9M | $1.1M |
| Mirae Asset Global Investments Co. | ADD | +25.4% | $282.0K | $25.0K |
| Farther Finance Advisors | ADD | +90.5% | $3.0K | $1.0K |
Key Facts
- 3 institutional buyers added $1.1M in aggregate, 0 sellers
- Largest buyer: Principal Financial Group added $1.1M (47.9% share increase) to a $4.9M position
- Mirae Asset Global Investments added $25K (25.4% increase) to a $282K position
- Farther Finance Advisors added $1K (90.5% increase) to a $3K position
- All buyers are asset managers (active value type), no hedge funds or activists
- Confluence score 0/100: no open-market insider buying to corroborate the signal
- Total institutional activity ($1.1M) is ~0.02% of Oruka's $6.4B market cap
Financial Impact
Three asset managers accumulated $1.1M in new positions; no selling. The total is immaterial relative to the $6.4B market cap.
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound
- No insider buying to confirm institutional conviction
- All additions are small and from asset managers, not high-conviction hedge funds
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ORKA-2026-Q3 |
Track record
40 reports on ORKA
7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 11 of 11 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $104.40 settles Dec 15
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $106.15 settles Dec 15
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $104.89 settles Dec 15
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 settles Dec 14
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 settles Dec 14
- Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 settles Dec 9
- Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Viewing Entry $99.55 settles Dec 2
- Nov 2, 202614d ago 144 Neutral 3/10 Entry $99.55 settles Dec 2
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 settles Nov 23
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers